• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

RealTalk MS

  • Home
  • Past Episodes
  • Videos
  • About RealTalk MS
  • Press Kit
  • Contact Us

Past Podcast Episodes

Episode 30: Dr. Matthew Miles & MS Research Australia


We have a lot to talk about in this podcast episode! First, a big announcement…the RealTalk MS Podcast has its own Amazon Alexa Skill! If you already own an Amazon Echo, Dot, or any Alexa-enabled device, you can access all sorts of convenient features for listening to RealTalk MS! (And if you don't yet have an Alexa-enabled device, this might be one more reason to get one!)
Matthew Miles and MS Research Australia
My guest on the podcast is Dr. Matthew Miles, the CEO of MS Research Australia, the largest non-profit organization dedicated to funding, coordinating, and advocating for MS research in Australia. We're talking with Matthew about some of the amazing research collaborations that MS Research Australia is driving in Australia and around the world. (NOTE: During our conversation, Dr. Miles references the MS Research Australia website as “www.msra.org”. The correct website is www.msra.org.au. Sorry for the confusion!)

 ____________

The Alexa Announcement  2:22

Introducing Matthew Miles & MS Research Australia  5:48

Study Shows MS Progresses Faster in African-Americans  6:46

Gilenya Shown To Be Effective in Delaying MS Progression & Disease Activity in Pediatric MS  8:00

MS Disease-Modifying Drugs May Lose Effectiveness As You Age 9:46

Interview with Dr. Matthew Miles 11:20

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

The RealTalk MS Podcast Alexa Skill

STUDY: MS Progresses Faster in African-Americans

STUDY: Gilenya Effective in Delaying MS Progression & Disease Activity in Pediatric MS Patients

MS Disease-Modifying Therapies May Be Less Effective As You Age

MS Research Australia

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 30
Guest: Dr. Matthew Miles
Hosted By: Jon Strum

Tags: MS, multiple sclerosis, Alexa, Matthew Miles, MS Research Australia, AAN, Gilenya

 

Filed Under: Uncategorized

RealTalk MS Episode 29: New Treatment Guidelines For MS Announced


The American Academy of Neurology (AAN) is holding its Annual Meeting this week in Los Angeles. And with more than 10,000 neurologists all in one place, we're talking about a LOT of news coming out of that conference.
Just some of the topics we're talking about on this week's podcast:
  • The AAN announced new guidelines for treating MS.
  • A new study will convince you to begin MS disease-modifying therapy sooner, rather than later.
  • The National MS Society has announced $14.2 million dollars in funding for 45 new research projects aimed at slowing, stopping, and ending MS.
  • Genentech announced some good news for MS patients taking Ocrevus.
  • Biogen announced the results of several MS research studies.
  • Computer-based cognitive training can improve memory for people living with MS.

My guest on the podcast is 3-time Stanley Cup winner and and star of the National Hockey League's Chicago Blackhawks, Bryan Bickell. Bryan retired from hockey last year, after being diagnosed with MS.

Bryan Bickell

We'll talk with Bryan about what it was like to get that diagnosis, what it was like to score that very memorable final goal of his career, and what lies ahead for him. (NOTE: During our conversation, Bryan references a website as “My Fighting Hockey Story”. The correct website is MyFightingStory.com. Sorry for any confusion!)

____________

AAN Announces New Treatment Guidelines For MS  2:02

Study Indicates Importance of Starting MS Treatment ASAP  4:01

National MS Society Investing $14.2 Million in New Research  6:54

Genentech Has Good News For MS Patients Taking Ocrevus  8:25

Biogen Study Correlates MS Cognitive Decline to Socioeconomic Demographics  10:35

Computer-Based Cognitive Training Improves Memory for People Living with MS  12:49

The MSUnderstood Cafe Gives People A Taste of MS  13:49

Interview with hockey star Bryan Bickell  16:03

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

American Academy of Neurology Annual Meeting
AAN Announces New Treatment Guidelines for MS
Early Versus Later Treatment Start in Multiple Sclerosis – A Register Based Cohort Study
Register for Interim Analysis of the Ocrelizumab Biomarker Outcome Evaluation Study in Multiple Sclerosis Research Study
Benchmarks of Cognitive Performance in a Large, Representative Patient Population
Cognitive Training and Neuropsychological Performance of Patients with Multiple Sclerosis
The MSUnderstood Cafe
Bryan Bickell's Story
 ___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 29
Guest: Bryan Bickell
Hosted By: Jon Strum

Tags: MS, multiple sclerosis, AAN, AANAM, MS Treatment Guidelines, Genentech, Biogen, Ocrevus, NMSS, National MS Society, Roche, MSUnderstood Cafe, Bryan Bickell, RealTalkMS

 

Filed Under: Uncategorized

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 213
  • Page 214
  • Page 215
  • Page 216
  • Page 217
  • Interim pages omitted …
  • Page 229
  • Go to Next Page »

Primary Sidebar

ARE YOU ON OUR MAILING LIST?

Sign up to receive email updates from RealTalk MS. You’ll get a personal advance heads-up about every upcoming podcast episode.

And P.S. — We promise to keep your private information private! We won’t sell it, trade it, or share it.

DOWNLOAD THE APP!

It’s the easiest way to connect with the RealTalk MS podcast. You’ll never miss another episode.

AND…we’re sharing free bonus content available ONLY in the RealTalk MS app.

Download the FREE RealTalk MS app today. It’s your VIP pass to the RealTalk MS community.

Follow RealTalk MS!


Connect With Us

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

Copyright © 2025 RealTalk MS